Short answer
Surgery Partners, Inc. (SGRY) filed an 8-K current report with the SEC on November 9, 2026 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Merger consideration raised to $25.00 per share in cash, improving shareholder economics.
Surgery Partners, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 1.01 · Entry into a Material Definitive Agreement
- Merger consideration raised to $25.00 per share in cash, improving shareholder economics
- 10% annual ticking fee after March 1, 2027 if approval is obtained but closing is delayed, capped at $1.61 per share
- Parent faces broader antitrust-remediation obligations, reducing regulatory execution flexibility
- Company termination fee increased to approximately $149.1 million, discouraging competing proposals
- Superior-proposal termination before shareholder approval requires reimbursement of buyer expenses up to $8.25 million
Item 7.01 · Regulation FD Disclosure
- Press release announces entry into an Amendment, making the revised agreement the key investor focus
- Exhibit 99.1 contains the amendment announcement and likely substantive terms
Item EX-99.1 · Exhibit EX-99.1
- Amended HealthSpan merger raises consideration to $25 per share, valuing Surgery Partners at up to approximately $6.0 billion enterprise value
- Ticking Fee adds up to $1.61 per share if approval occurs before March 1, 2027 but closing extends to October 23, 2027
- Competing third-party proposal offered $28 per share, but the Special Committee rejected it as not a Superior Proposal due to greater timing and regulatory risks
- Bain Capital owns approximately 39% and remains committed to voting for HealthSpan, but will roll over its shares without receiving merger consideration
- Closing remains targeted for the first quarter of 2027, subject to shareholder and regulatory approvals
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Surgery Partners, Inc. 8-K filings
Get the next SGRY 8-K as it lands
Follow SGRY for push alerts, or ask the research agent what this filing means.